For the purposes of this Regulation, the following definitions apply:
‘organism’ means an organism as defined in Article 2, point (1), of Directive 2001/18/EC;
‘genetically modified organism’ or ‘GMO’ means a genetically modified organism as defined in Article 2, point (2), of Directive 2001/18/EC, excluding organisms obtained through the techniques of genetic modification listed in Annex I B to Directive 2001/18/EC;
‘deliberate release’ means deliberate release as defined in Article 2, point (3), of Directive 2001/18/EC;
‘placing on the market’ means placing on the market as defined in Article 2, point (4), of Directive 2001/18/EC;
‘food’ means food as defined in Article 2 of Regulation (EC) No 178/2002;
‘feed’ means feed as defined in Article 3, point (4), of Regulation (EC) No 178/2002;
‘plant’ means a plant as defined in Article 2, point (1), of Regulation (EU) 2016/2031 of the European Parliament and of the Council [Regulation (EU) 2016/2031 of the European Parliament and of the Council of 26 October 2016 on protective measures against pests of plants, amending Regulations (EU) No 228/2013, (EU) No 652/2014 and (EU) No 1143/2014 of the European Parliament and of the Council and repealing Council Directives 69/464/EEC, 74/647/EEC, 93/85/EEC, 98/57/EC, 2000/29/EC, 2006/91/EC and 2007/33/EC (OJ L 317, 23.11.2016, p. 4, ELI: http://data.europa.eu/eli/reg/2016/2031/oj).];
‘plant reproductive material’ means plants capable of, and intended for, producing entire plants;
‘NGT plant’ means a genetically modified plant obtained by targeted mutagenesis or cisgenesis, or a combination thereof, and not containing any genetic material originating from outside the gene pool for conventional breeding purposes that might have been temporarily inserted during the development of that plant;
‘targeted mutagenesis’ means mutagenesis techniques resulting in one or more modifications of the DNA sequence at targeted locations in the genome of an organism;
‘cisgenesis’ means techniques of genetic modification resulting in the insertion, into the genome of an organism, of genetic material already present in the gene pool for conventional breeding purposes;
‘gene pool for conventional breeding purposes’ means the total genetic information available in one species and in other taxonomic species with which that species can be crossed, including by using advanced techniques such as embryo rescue, induced polyploidy and bridge crosses;
‘category 1 NGT plant’ means an NGT plant that:
fulfils the criteria of equivalence to conventional plants set out in Annex I and does not include any trait listed in Annex II among the traits intended to be conveyed by the genetic modifications; or
is the progeny of NGT plants as referred to in point (a), including progeny obtained by crossing of such plants, and contains no further modifications obtained through targeted mutagenesis, cisgenesis or other techniques that would make it subject to Directive 2001/18/EC or Regulation (EC) No 1829/2003;
‘category 2 NGT plant’ means an NGT plant other than a category 1 NGT plant;
‘NGT plant for food use’ means an NGT plant that may be used as food or as a source material for the production of food;
‘NGT plant for feed use’ means an NGT plant that may be used as feed or as a source material for the production of feed;
‘produced from NGT plants’ means derived, in whole or in part, from NGT plants, but not containing or consisting of NGT plants;
‘NGT product’ means food and feed containing, consisting of or produced from NGT plants, and products, other than food and feed, containing or consisting of such plants;
‘category 1 NGT product’ means an NGT product where the NGT plant it contains, consists of or is produced from is a category 1 NGT plant;
‘category 2 NGT product’ means an NGT product where the NGT plant it contains, consists of or is produced from is a category 2 NGT plant;
‘small or medium-sized enterprise’ or ‘SME’ means an SME within the meaning of Commission Recommendation 2003/361/EC [Commission Recommendation 2003/361/EC of 6 May 2003 concerning the definition of micro, small and medium-sized enterprises (OJ L 124, 20.5.2003, p. 36, ELI: http://data.europa.eu/eli/reco/2003/361/oj).];
‘chimeric protein’ means a protein created through the joining of two or more genes or parts of genes that originally coded for separate proteins.